Concepedia

Andrew H. Ko

AH

91

Publications

13.6K

Citations

45

H-Index

2002

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Stanford University

Andrew H. Ko is an author at University of California, San Francisco specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2002–2025

91

Publications

91

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

Eric A. Collisson, Anguraj Sadanandam, Peter Olson et al. · Nature Medicine · 2011 · 1.9K citations · Full text

, , +7

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly, Jaffer A. Ajani, Thomas Zander et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.2K citations · Full text

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

Kohei Shitara, Eric Van Cutsem, Yung‐Jue Bang et al. · JAMA Oncology · 2020 · 1.1K citations · Full text

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1K citations

, , +18

Rows per page

1–5 of 91